SCHEMBL15038352

SCHEMBL15038352

Cc1c(N)nnc(-c2ccc(F)cc2)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.49
ADORA1 P30542 4/20 0.49
ADORA2B P29275 2/20 0.49
ADORA3 P0DMS8 1/20 0.43
MAPK14 Q16539 3/20 0.41
SRC P12931 1/20 0.39
BRAF P15056 1/20 0.39
KDR P35968 1/20 0.39
ALDH1A1 P00352 4/20 0.39
ALOX5 P09917 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 6/20 0.39
MAPT P10636 2/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15038309 0.80 MKNK1 (0.50) ADORA2AADORA1SRCBRAFKDR
SCHEMBL15038351 0.80 CLK4 (0.52) ADORA2AADORA1ADORA2BMAPK14KDR
SCHEMBL26242512 0.80 ADORA2A (0.44) ADORA2AADORA1ADORA2BADORA3MAPK14
SCHEMBL15038342 0.80 LMNA (0.40) ADORA2AADORA1MAPK14SRCBRAF
SCHEMBL15038312 0.78 NPC1 (0.45) MAPK14ALDH1A1RAB9AKDM4ECYP1A2
SCHEMBL15038353 0.78 KMT2A (0.45) ADORA2AADORA1ALDH1A1RAB9AKDM4E
SCHEMBL15038318 0.73 SMO (0.48) SRCKDRALDH1A1KDM4E
SCHEMBL14959329 0.72 KDM4E (0.56) ADORA2AADORA1ADORA2BALDH1A1KDM4E
SCHEMBL30617006 0.72 MAPK14 (0.41) ADORA2AADORA1ADORA2BADORA3MAPK14
SCHEMBL20075444 0.70 MAPK14 (0.60) ADORA2AADORA1ADORA2BADORA3MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318389-B1 PYRIDAZINE DERIVATIVES AS SMO INHIBITORS NOVARTIS AG (CH) 2013-06-19 EP disclosed